Indisulam. Eisai |
| |
| Authors: | Supuran Claudiu T |
| |
| Institution: | Universita degli Studi di Firenze, Dipartimento di Chimica, Via della Lastruccia, 3, Rm 188, I-50019 Sesto Fiorentino, Italy. claudiu.supuran@unifi.it |
| |
| Abstract: | Eisai and the EORTC are developing indisulam, a sulfonamide which inhibits progression from the G(1) phase of the cell cycle, for the potential treatment of cancer 338089]. As of January 2001, indisulam was in phase II trials in Europe for the treatment of solid tumors, and phase II US studies have been ongoing since March 2001 400862]. In 2001, clinical development of the drug in Japan was scheduled to begin in fiscal year 2002 396633]. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
